AstraZeneca PLCChange company Symbol lookupSelect an option...AZN AstraZeneca PLCOTGLF CD Projekt SAHRL Hormel Foods CorpIPOF Social Capital Hedosophia Holdings Corp VINIO NIO IncNRT North European Oil Royalty TrustJNJ Johnson & JohnsonSTAG STAG Industrial IncTM Toyota Motor CorpHSIC Henry Schein IncGo
Based in United Kingdom
AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of its SGLT2 and GLP-1 franchises in chronic kidney disease (CKD) and heart failure (HF). It has approximately 38 projects in Phase I, including 26 new molecular entities (NMEs), and 12 oncology combination projects. It has approximately 43 projects in Phase II, including 25 NMEs; six additional indications for projects that have reached phase II, and 12 oncology combination projects. It has approximately 22 projects in late-stage development, either in Phase III/pivotal Phase II studies or under regulatory review.
American Depositary Receipt (ADR) Fee
ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| November 5, 2020 | Q3 2020 Earnings Release | $0.47 | $0.44 to $0.44 | $0.50 |
| July 30, 2020 | Q2 2020 Earnings Release | $0.48 | $0.44 to $0.44 | $0.37 |
| April 29, 2020 | Q1 2020 Earnings Release | $0.53 | $0.47 to $0.47 | $0.45 |
| February 14, 2020 | Q4 2019 Earnings Release | $0.45 | $0.52 to $0.66 | -- |
Past Dividends
| Ex-dividend date | Amount | Record date | Pay date |
|---|---|---|---|
| August 13, 2020 | $0.45 | August 14, 2020 | September 14, 2020 |
| February 27, 2020 | $0.95 | February 28, 2020 | March 30, 2020 |
Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.
, , , Copyright © 2021. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.